1. Field of the Invention
The illustrative embodiments relate generally to a disc-pump valve for managing fluid flow therethrough and, more specifically, but not by way of limitation, to a disc pump having a perimeter valve configuration.
2. Description of Related Art
Conventional valves typically operate at frequencies below 500 Hz. For example, many conventional compressors typically operate at 50 or 60 Hz. A linear resonance compressor known in the art operates between 150 and 350 Hz. Some applications, require valves that are capable of operating at much higher frequencies, 20 kHz and higher, for example. Valves that operate at these high frequencies are not commonly available. For example, many portable electronic devices, including medical devices, require pumps that are relatively small in size to deliver a positive pressure or to provide a vacuum. Consequently, these relatively small pumps require even smaller valves that must operate at very high frequencies to be effective. Moreover, these valves must operate at frequencies beyond the range of human hearing so that the valves are inaudible in operation. To operate at these high frequencies, the valve must be responsive to a high frequency oscillating pressure that can be rectified to create a net flow of fluid through the pump.
According to an illustrative embodiment, a disc pump valve for controlling the flow of fluid through a disc pump includes a pump base having an elliptical shape and at least one aperture extending through the pump base. The pump base comprises a first end wall and a sealing surface. The disc pump also includes an isolator overlying the pump base, the isolator having an isolator valve aperture extending through the isolator at or near the periphery of the isolator and partially overlying the cavity to form an outlet. In addition, the disc pump includes a valve flap disposed between the pump base and the isolator. The valve flap has one or more valve flap apertures arranged about the periphery of the valve flap beyond the periphery of the cavity and underlying an isolator valve aperture. The valve flap seals against the sealing surface to close the pump outlet and prevent fluid from flowing from the pump outlet through the cavity. The valve flap also flexes away from the sealing surface to allow fluid to pass from the cavity through the pump outlet.
According to another illustrative embodiment, a disc pump valve for controlling the flow of fluid through a disc pump comprises a pump base having an elliptical shape and at least one aperture extending through the pump base, the pump base comprising a first end wall and a sealing surface. An isolator overlies the pump base and has an isolator valve aperture extending through the isolator at or near the periphery of the isolator and partially overlying the cavity to form an outlet. A valve flap is disposed between the pump base and the isolator. The valve flap has one or more valve flap apertures that are arranged about the periphery of the valve flap beyond the periphery of the cavity and underlying an isolator valve aperture. The disc pump valve also includes a plurality of isolator valve apertures, each of the isolator valve apertures extending through the isolator at or near the periphery of the isolator and partially overlying the cavity to form a plurality of pump outlets. In addition, the disc pump valve includes a plurality of valve flap apertures. Each of the valve flap apertures are arranged about the periphery of the valve flap beyond the periphery of the cavity, and underlying an isolator valve aperture. Each of the isolator valve apertures overlies a plurality of valve flap apertures. The valve flap seals against the sealing surface to close the pump outlet and prevent fluid from flowing from the pump outlet through the cavity. The valve flap flexes away from the sealing surface to allow fluid to pass from the cavity through the pump outlet.
Other objects, features, and advantages of the illustrative embodiments are disclosed herein and will become apparent with reference to the drawings and detailed description that follow.
In the following detailed description of illustrative embodiments, reference is made to the accompanying drawings that form a part hereof. By way of illustration, the drawings show specific preferred embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is understood that other embodiments may be utilized and that logical structural, mechanical, electrical, and chemical changes may be made without departing from the spirit or scope of the invention. To avoid detail not necessary to enable those skilled in the art to practice the embodiments described herein, the description may omit certain information known to those skilled in the art. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the illustrative embodiments is defined only by the appended claims.
A micropump, such as a disc pump, is a suitable application for a valve that operates at a high frequency, e.g., beyond the range of human hearing. At such frequencies, the pump may be extremely small in size and suitable for integration into a wide range of portable electronic devices where pressure or vacuum delivery is required. The disc pump may include an actuator, such as a piezoelectric actuator, to cause oscillatory motion and displacement oscillations of a driven end wall within the disc pump. When the actuator generates an oscillatory motion of the end wall, the displacement oscillations may generate radial oscillations of the fluid pressure within the pump. These radial oscillation of fluid pressure may cause fluid to flow through apertures in the pump base and apertures in the end wall, which may be inlet apertures and outlet apertures, respectively. To generate a pressure differential, the pump includes one or more valves that allow fluid to flow through the disc pump in only one direction. For the valves to operate at the high frequencies generated by the actuator, the valves may have an extremely fast response time such that the valves are able to open and close on a time scale that is shorter than the time scale of the pressure variations.
Referring now to
The valve flap 130 is generally circular in shape having a cavity-facing surface and an isolator-facing surface 132. The cavity-facing surface has a central portion that forms a second end wall 131 that closes the cavity 115 of the pump base 110 and a peripheral portion 133 extending from the side wall 111 to cover the upper surface 119 of the pump base 110 on which the valve flap 130 is mounted. The valve flap 130 comprises perforations 135 positioned along the peripheral portion 133 of the valve flap 130, each one of which is aligned over the indentations 123 in the upper surface 119 of the pump base 110. The perforations 135 may include a plurality of the valve-flap apertures 531-535 (see, for example,
About the periphery of the disc pump 100, the valve flap 130 is sandwiched between the isolator 150 and the pump base 110 so that the periphery is immobilized in a direction that is substantially perpendicular the surface of the valve flap 130. Yet the valve flap 130 is sufficiently flexible to allow the unconstrained portion of the valve flap 130 to deform, thereby opening a fluid flow path from the cavity 115 to isolator valve apertures 155, as described in more detail below.
The isolator 150 is also generally circular in shape and has a central portion and a peripheral portion 151. The piezoelectric disc 145 is mechanically coupled to a first side of the isolator 150 at the central portion. At the peripheral portion 151, the opposing side of the isolator 150 is mounted to the valve flap 130 over the upper surface 119 of the pump base 110. The peripheral portion 151 of the isolator 150 covers the isolator-facing surface 132 of the valve flap 130 which is sandwiched between the isolator 150 and the upper surface 119 of the pump base 110. The isolator 150 comprises relief apertures 153 through the peripheral portion 151 extending radially outwardly from the periphery of the piezoelectric disc 145 to provide additional flexibility when the piezoelectric disc 145 is energized and vibrates. The isolator 150 further comprises isolator valve apertures 155 positioned between the relief apertures 153 and the edge of the peripheral portion 151 of the isolator 150, each one of which is aligned to provide an opening for the perforations 135 of the valve flap 130. The isolator valve apertures 155 extend radially inwardly from the perforations 135 and the side wall 111 to overlap a peripheral portion 157 of the cavity 115 with the valve flap 130 still separating the isolator valve apertures 155 from the cavity 115.
Referring more specifically to
When the pressure in the isolator valve aperture 155 equals or exceeds the pressure in the cavity 115 to create a differential pressure as indicated by arrow 138, the peripheral portion 133 of the valve flap 130 remains seated on the upper surface 119 of the pump base 110 to block fluid flow to the cavity 115. Since this is the original shape of the valve flap 130, the valve flap 130 is the to be normally biased in a “closed position” in which the valve flap 130 is substantially flat and seated on the sealing surface 121 of the pump base 110. When the pressure in the cavity 115 exceeds the pressure in the isolator valve aperture 155 to create a differential pressure in the opposite direction, the resultant force and fluid flow motivates the valve flap 130 away from the closed position to overcome the bias of the valve flap 130 and break the seal with the sealing surface 121 of the pump base 110. When the valve flap 130 is in this deformed state, the fluid flow path is formed by the valve flap 130 and the upper surface 119 of the pump base 110. As shown in
Turning now to
As noted above, the disc pump 100 also comprises a plurality of valves formed by the arrangement of the pump base 110, the valve flap 130 and the isolator 150. The plurality of valves are disposed about the periphery of the disc pump 100 and allow fluid to flow through the disc pump 100 in only one direction, as described above. For the valves to operate at the high frequencies generated by the actuator 140, the valves must have an extremely fast response time such that the valves are able to open and close on a time scale significantly shorter than the time scale of the pressure variations. The valves are disposed about the periphery of the cavity 115 so that fluid is drawn into the cavity 115 only through the inlet apertures 125. The fluid is expelled from the cavity 115 through pump outlets formed by the isolator valve apertures 155 as indicated by the solid arrows 128, thereby providing a source of reduced pressure at the inlet apertures 125. The term “reduced pressure” as used herein generally refers to a pressure less than the ambient pressure where the disc pump 100 is located. Although the term “vacuum” and “negative pressure” may be used to describe the reduced pressure, the actual pressure reduction may be significantly less than the pressure reduction normally associated with a complete vacuum. The pressure is “negative” in the sense that it is a gauge pressure, i.e., the pressure is reduced below ambient atmospheric pressure. Unless otherwise indicated, values of pressure stated herein are gauge pressures. References to increases in reduced pressure typically refer to a decrease in absolute pressure, while decreases in reduced pressure typically refer to an increase in absolute pressure.
The pressure profile graphs of
Returning to
In the closed position illustrated in
In steady-state operation, pressure is applied against valve flap 130 by fluid in the cavity 115, which motivates the valve flap 130 away from the sealing surface 121, as shown in
The opening and closing of the valve flap 130 is a function of the change in direction of the differential pressure (ΔP) of the fluid across the valve flap 130. In
When the differential pressure changes back to a negative differential pressure (−ΔP) as indicated by the downward pointing arrow in
The differential pressure (ΔP) is assumed to be substantially uniform at the locations of the valves because the valve locations correspond to the peripheral pressure anti-node 212, as described above. Consequently, the cycling of the differential pressure (ΔP) between the positive differential pressure (+ΔP) and negative differential pressure (−ΔP) values can be represented by a square wave over the positive pressure time period (tP+) and the negative pressure time period (tP−), respectively, as shown in
Regarding material selection, the isolator 150 should be rigid enough to withstand the fluid pressure oscillations to which it is subjected without significant mechanical deformation relative to the valve flap 130 at the periphery of the cavity 115. As such, the isolator 150 may be formed from a polymer sheet material of uniform thickness such as, for example, PET or Kapton. In one embodiment, the isolator 150 may be made from Kapton sheeting having a thickness of less than about 200 microns. The isolator 150 may also be made from a thin metal sheet of uniform thickness such as, for example, steel or brass, or another suitable flexible material. In another embodiment, the isolator 150 may be made from steel sheeting having a thickness of less than about 20 microns. The isolator 150 may be made of another flexible material suitable to facilitate vibration of the actuator 140 as described above. The isolator 150 may be glued, welded, clamped, soldered, or otherwise attached to the actuator 140 depending on the material used, and either the same process or a different process may be used to attach the isolator 150 to the pump base 110.
The valve flap 130 may be formed from a lightweight material, such as a metal or polymer film. In one embodiment, when fluid pressure oscillations of about 20 kHz or greater are present, the valve flap 130 may be formed from a thin polymer sheet between, about 1 micron and about 20 microns in thickness. For example, the valve flap 130 may be formed from polyethylene terephthalate (PET) or a liquid crystal polymer film approximately 3 microns in thickness. As shown in
To estimate the pressure drop for flow through the apertures, a computational model may be applied that considers the fluid dynamic viscosity, the flow rate through the apertures, and the thickness of the valve flap 130. When the valve flap 130 is in the open position shown in
Consideration also should be given to maintaining the stress experienced by the valve flap 130 within acceptable limits during operation of the valve, which typically requires a larger sealing surface 121. In one embodiment, the gap dgap value may be selected such that the gap pressure drop is equal to the hole pressure drop. In one embodiment, the size of the gap dgap falls within an approximate range between about 5 microns and about 150 microns, although more preferably within a range between about 15 and about 50 microns.
The maximum stress experienced by the material of the valve flap 130 in operation may be estimated using computational models. In one embodiment of the invention, the valve flap 130 is formed from a thin polymer sheet, such as Mylar having a Poisson ratio of 0.3, and is clamped to the sealing surface 121 about the perimeter of the pump base 110. Considering the high number of stress cycles applied to the valve flap 130 during the operation of the valve, the maximum stress per cycle tolerated by the valve flap 130 should be significantly lower than the yield stress of the material of the valve flap 130. Limiting the maximum stress per cycle to be significantly less than the yield stress of the material of the valve flap 130 in order to reduce the possibility that the valve flap 130 suffers a fatigue fracture, especially at the portion of the valve flap 130 that flexes upward to allow fluid flow. Based on fatigue data compiled for a high number of cycles with respect to similar valve structures, it has been determined that the actual yield stress of the material of the valve flap 130 should be at least about four times greater than the stress applied to the material of the valve flap 130 (e.g., 16, 34, and 43 MPa as calculated above). Thus, the valve flap material should have a yield stress as high as 150 MPa to minimize the likelihood of such fractures for a maximum equivalent diameter of the isolator valve apertures 155 in this case of approximately 200 microns.
Reducing the equivalent diameter of the isolator valve apertures 155 beyond the maximum equivalent diameter of the isolator valve apertures 155 may be desirable as it further reduces valve flap 130 stress and has no significant effect on valve flow resistance until the diameter of the equivalent isolator valve apertures 155 approaches the same size as the gap dgap. Further, reduction in the size of the isolator valve apertures 155 permits the inclusion of an increased number of isolator valve apertures 155 per unit area of the isolator surface for a given sealing length (s). However, the size of the isolator valve apertures 155 may be limited, at least in part, by the manner in which the isolator 150 is fabricated. For example, chemical etching limits the size of the isolator valve apertures 155 to be equal to or greater than the thickness of the isolator 150 in order to achieve repeatable and controllable results. In one embodiment, the isolator valve apertures 155 in the isolator 150 are between about 20 microns and about 500 microns in diameter. In other embodiments the isolator valve apertures 155 in the isolator 150 are between about 100 and about 200 microns in diameter depending on the other factors described above.
Within the disc pump 100, the thickness of the material of the valve flap 130 (e.g., 3 μm Mylar) is a factor in the speed of the valve operation and therefore a contributor to the performance of the disc pump 100. As a result, pumps assembled with about a 1.5 μm valve flap 130 with about a 20 μm gap may yield increased performance over valves having about a 3 μm valve flap with about a 20 μm gap. A wider valve gap may also increase performance, such that about a 60 μm gap may yield improved performance over about a 20 μm gap with about a 3 μm valve flap 130. It is possible to increase performance by creating a valve having, for example, a thinner valve flap 130 of about a 1.5 μm thickness and about a 60 μm gap. Yet to create such a valve, material concerns must be overcome to address the additional strain place on a thinner material. This concern is mitigated by biasing the valve flap 130 toward the center of the valve cavity 115. The individual valve flap apertures 531-535 may be formed partially by precision injection molding the valve flap 130, and partly by laser drilling or a similar process. To form the pump 100 and integrated valves, the valve flap 130 can be directly mounted to the isolator 150. The isolator 150 and valve flap 130 may then be fastened to the pump base 110 by a suitable joining process, such as heat staking.
The inlet apertures 125 are shown in, e.g.,
Together, the illustrative embodiments provide a method for forming valves around the periphery of a pump cavity 115 at the location of the peripheral pressure anti-node 212. By providing an increased area for including valves in the pump cavity 115, the disc pump 100 of the illustrative embodiments may provide greater flow than a similar pump having a centrally mounted valve. By isolating incorporating a multitude of small valves into the structure of the disc pump 100, manufacturing may be simplified. Moreover, the multitude of valves provides a degree of redundancy, such that if one of the valve flap apertures is blocked or is fractured, the remaining valves will remain functional.
It should be apparent from the foregoing that embodiments having significant advantages have been provided. While the embodiments are shown in only a few of its forms, it is not just limited but is susceptible to various changes and modifications without departing from the spirit thereof.
The present invention claims the benefit, under 35 USC §119(e), of the filing of U.S. Provisional Patent Application Ser. No. 61/635,655, entitled “DISC PUMP WITH PERIMETER VALVE CONFIGURATION,” filed Apr. 19, 2012, by Locke et al., which is incorporated herein by reference for all purposes.
Number | Name | Date | Kind |
---|---|---|---|
1355846 | Rannells | Oct 1920 | A |
2547758 | Keeling | Apr 1951 | A |
2632443 | Lesher | Mar 1953 | A |
2682873 | Evans et al. | Jul 1954 | A |
2910763 | Lauterbach | Nov 1959 | A |
2969057 | Simmons | Jan 1961 | A |
3066672 | Crosby, Jr. et al. | Dec 1962 | A |
3367332 | Groves | Feb 1968 | A |
3520300 | Flower, Jr. | Jul 1970 | A |
3568675 | Harvey | Mar 1971 | A |
3648692 | Wheeler | Mar 1972 | A |
3682180 | McFarlane | Aug 1972 | A |
3826254 | Mellor | Jul 1974 | A |
4080970 | Miller | Mar 1978 | A |
4096853 | Weigand | Jun 1978 | A |
4139004 | Gonzalez, Jr. | Feb 1979 | A |
4165748 | Johnson | Aug 1979 | A |
4184510 | Murry et al. | Jan 1980 | A |
4233969 | Lock et al. | Nov 1980 | A |
4245630 | Lloyd et al. | Jan 1981 | A |
4256109 | Nichols | Mar 1981 | A |
4261363 | Russo | Apr 1981 | A |
4275721 | Olson | Jun 1981 | A |
4284079 | Adair | Aug 1981 | A |
4297995 | Golub | Nov 1981 | A |
4333468 | Geist | Jun 1982 | A |
4373519 | Errede et al. | Feb 1983 | A |
4382441 | Svedman | May 1983 | A |
4392853 | Muto | Jul 1983 | A |
4392858 | George et al. | Jul 1983 | A |
4419097 | Rowland | Dec 1983 | A |
4465485 | Kashmer et al. | Aug 1984 | A |
4475909 | Eisenberg | Oct 1984 | A |
4480638 | Schmid | Nov 1984 | A |
4525166 | Leclerc | Jun 1985 | A |
4525374 | Vaillancourt | Jun 1985 | A |
4540412 | Van Overloop | Sep 1985 | A |
4543100 | Brodsky | Sep 1985 | A |
4548202 | Duncan | Oct 1985 | A |
4551139 | Plaas et al. | Nov 1985 | A |
4569348 | Hasslinger | Feb 1986 | A |
4605399 | Weston et al. | Aug 1986 | A |
4608041 | Nielson | Aug 1986 | A |
4640688 | Hauser | Feb 1987 | A |
4655754 | Richmond et al. | Apr 1987 | A |
4664662 | Webster | May 1987 | A |
4710165 | McNeil et al. | Dec 1987 | A |
4733659 | Edenbaum et al. | Mar 1988 | A |
4743232 | Kruger | May 1988 | A |
4758220 | Sundblom et al. | Jul 1988 | A |
4787888 | Fox | Nov 1988 | A |
4826494 | Richmond et al. | May 1989 | A |
4838883 | Matsuura | Jun 1989 | A |
4840187 | Brazier | Jun 1989 | A |
4863449 | Therriault et al. | Sep 1989 | A |
4872450 | Austad | Oct 1989 | A |
4878901 | Sachse | Nov 1989 | A |
4897081 | Poirier et al. | Jan 1990 | A |
4906233 | Moriuchi et al. | Mar 1990 | A |
4906240 | Reed et al. | Mar 1990 | A |
4919654 | Kalt et al. | Apr 1990 | A |
4941882 | Ward et al. | Jul 1990 | A |
4953565 | Tachibana et al. | Sep 1990 | A |
4969880 | Zamierowski | Nov 1990 | A |
4985019 | Michelson | Jan 1991 | A |
5037397 | Kalt et al. | Aug 1991 | A |
5086170 | Luheshi et al. | Feb 1992 | A |
5092858 | Benson et al. | Mar 1992 | A |
5100396 | Zamierowski | Mar 1992 | A |
5134994 | Say | Aug 1992 | A |
5149331 | Ferdman et al. | Sep 1992 | A |
5167613 | Karami et al. | Dec 1992 | A |
5176663 | Svedman et al. | Jan 1993 | A |
5215522 | Page et al. | Jun 1993 | A |
5232453 | Plass et al. | Aug 1993 | A |
5261893 | Zamierowski | Nov 1993 | A |
5278100 | Doan et al. | Jan 1994 | A |
5279550 | Habib et al. | Jan 1994 | A |
5298015 | Komatsuzaki et al. | Mar 1994 | A |
5342376 | Ruff | Aug 1994 | A |
5344415 | DeBusk et al. | Sep 1994 | A |
5358494 | Svedman | Oct 1994 | A |
5437622 | Carion | Aug 1995 | A |
5437651 | Todd et al. | Aug 1995 | A |
5527293 | Zamierowski | Jun 1996 | A |
5549584 | Gross | Aug 1996 | A |
5556375 | Ewall | Sep 1996 | A |
5607388 | Ewall | Mar 1997 | A |
5636643 | Argenta et al. | Jun 1997 | A |
5645081 | Argenta et al. | Jul 1997 | A |
6071267 | Zamierowski | Jun 2000 | A |
6135116 | Vogel et al. | Oct 2000 | A |
6241747 | Ruff | Jun 2001 | B1 |
6287316 | Agarwal et al. | Sep 2001 | B1 |
6345623 | Heaton et al. | Feb 2002 | B1 |
6488643 | Tumey et al. | Dec 2002 | B1 |
6493568 | Bell et al. | Dec 2002 | B1 |
6553998 | Heaton et al. | Apr 2003 | B2 |
6814079 | Heaton et al. | Nov 2004 | B2 |
20020077661 | Saadat | Jun 2002 | A1 |
20020115951 | Norstrem et al. | Aug 2002 | A1 |
20020120185 | Johnson | Aug 2002 | A1 |
20020143286 | Tumey | Oct 2002 | A1 |
20020168278 | Jeon | Nov 2002 | A1 |
20040063217 | Webster | Apr 2004 | A1 |
20040074768 | Anex | Apr 2004 | A1 |
20040118865 | Maruyama | Jun 2004 | A1 |
20060076068 | Young | Apr 2006 | A1 |
20060232167 | Jordan | Oct 2006 | A1 |
20070240989 | Levitan | Oct 2007 | A1 |
20090148318 | Kamitani | Jun 2009 | A1 |
20090188576 | Kang | Jul 2009 | A1 |
20100074775 | Yamamoto et al. | Mar 2010 | A1 |
20100310398 | Janse Van Rensburg | Dec 2010 | A1 |
20110081267 | McCrone et al. | Apr 2011 | A1 |
20110186765 | Jaeb | Aug 2011 | A1 |
20110190670 | Jaeb et al. | Aug 2011 | A1 |
Number | Date | Country |
---|---|---|
550575 | Mar 1986 | AU |
745271 | Apr 1999 | AU |
755496 | Feb 2002 | AU |
2005436 | Jun 1990 | CA |
26 40 413 | Mar 1978 | DE |
43 06 478 | Sep 1994 | DE |
295 04 378 | Oct 1995 | DE |
0100148 | Feb 1984 | EP |
0117632 | Sep 1984 | EP |
0161865 | Nov 1985 | EP |
0358302 | Mar 1990 | EP |
1018967 | Aug 2004 | EP |
692578 | Jun 1953 | GB |
2 195 255 | Apr 1988 | GB |
2 197 789 | Jun 1988 | GB |
2 220 357 | Jan 1990 | GB |
2 235 877 | Mar 1991 | GB |
2 329 127 | Mar 1999 | GB |
2 333 965 | Aug 1999 | GB |
4129536 | Apr 1992 | JP |
71559 | Apr 2002 | SG |
8002182 | Oct 1980 | WO |
8704626 | Aug 1987 | WO |
9010424 | Sep 1990 | WO |
9309727 | May 1993 | WO |
9420041 | Sep 1994 | WO |
9605873 | Feb 1996 | WO |
9718007 | May 1997 | WO |
9913793 | Mar 1999 | WO |
Entry |
---|
N.A. Bagautdinov, “Variant of External Vacuum Aspiration in the Treatment of Purulent Diseases of the Soft Tissues,” Current Problems in Modern Clinical Surgery: Interdepartmental Collection, edited by V. Ye Volkov et al. (Chuvashia State University, Cheboksary, U.S.S.R. 1986);pp. 94-96 (certified translation). |
Louis C. Argenta, MD and Michael J. Morykwas, PhD; “Vacuum-Assisted Closure: A New Method for Wound Control and Treatment: Animal Studies & Basic Foundation”; Annals of Plastic Surgery, vol. 38, No. 6, Jun. 1997; pp. 553-562. |
Susan Mendez-Eastmen, RN; “When Wounds Won't Heal” RN Jan. 1998, vol. 61 (1); Medical Economics Company, Inc., Montvale, NJ, USA; pp. 20-24. |
James H. Blackburn, II, MD, et al; “Negative-Pressure Dressings as a Bolster for Skin Grafts”; Annals of Plastic Surgery, vol. 40, No. 5, May 1998, pp. 453-457. |
John Masters; “Reliable, Inexpensive and Simple Suction Dressings”; Letters to the Editor, British Journal of Plastic Surgery, 1998, vol. 51 (3), p. 267; Elsevier Science/The British Association of Plastic Surgeons, UK. |
S.E. Greer, et al “The Use of Subatmospheric Pressure Dressing Therapy to Close Lymphocutaneous Fistulas of the Groin” British Journal of Plastic Surgery (2000), vol. 53, pp. 484-487. |
George V. Letsou, MD., et al; “Stimulation of Adenylate Cyclase Activity in Cultured Endothelial Cells Subjected to Cyclic Stretch”; Journal of Cardiovascular Surgery, vol. 31, 1990, pp. 634-639. |
Orringer, Jay, et al; “Management of Wounds in Patients with Complex Enterocutaneous Fistulas”; Surgery, Gynecology & Obstetrics, Jul. 1987, vol. 165, pp. 79-80. |
International Search Report for PCT International Application PCT/GB95/01983; Nov. 23, 1995. |
PCT International Search Report for PCT International Application PCT/GB98/02713; Jan. 8, 1999. |
PCT Written Opinion; PCT International Application PCT/GB98/02713; Jun. 8, 1999. |
PCT International Examination and Search Report, PCT International Application PCT/GB96/02802; Jan. 15, 1998 & Apr. 29, 1997. |
PCT Written Opinion, PCT International Application PCT/GB96/02802; Sep. 3, 1997. |
Dattilo, Philip P., Jr., et al; “Medical Textiles: Application of an Absorbable Barbed Bi-directional Surgical Suture”; Journal of Textile and Apparel, Technology and Management, vol. 2, Issue 2, Spring 2002, pp. 1-5. |
Kostyuchenok, B.M., et al; “Vacuum Treatment in the Surgical Management of Purulent Wounds”; Vestnik Khirurgi, Sep. 1986, pp. 18-21 and 6 page English translation thereof. |
Davydov, Yu. A., et al; “Vacuum Therapy in the Treatment of Purulent Lactation Mastitis”; Vestnik Khirurgi, May 14, 1986, pp. 66-70, and 9 page English translation thereof. |
Yusupov. Yu. N., et al; “Active Wound Drainage”, Vestnik Khirurgi, vol. 138, Issue 4, 1987, and 7 page English translation thereof. |
Davydov, Yu. A., et al; “Bacteriological and Cytological Assessment of Vacuum Therapy for Purulent Wounds”; Vestnik Khirurgi, Oct. 1988, pp. 48-52, and 8 page English translation thereof. |
Davydov, Yu. A., et al; “Concepts for the Clinical-Biological Management of the Wound Process in the Treatment of Purulent Wounds by Means of Vacuum Therapy”; Vestnik Khirurgi, Jul. 7, 1980, pp. 132-136, and 8 page English translation thereof. |
Chariker, Mark E., M.D., et al; “Effective Management of incisional and cutaneous fistulae with closed suction wound drainage”; Contemporary Surgery, vol. 34, Jun. 1989, pp. 59-63. |
Egnell Minor, Instruction Book, First Edition, 300 7502, Feb. 1975, pp. 24. |
Egnell Minor: Addition to the Users Manual Concerning Overflow Protection—Concerns all Egnell Pumps, Feb. 3, 1983, p. 1. |
Svedman, P.: “Irrigation Treatment of Leg Ulcers”, The Lancet, Sep. 3, 1983, pp. 532-534. |
Chinn, Steven D. et al.: “Closed Wound Suction Drainage”, The Journal of Foot Surgery, vol. 24, No. 1, 1985, pp. 76-81. |
Arnljots, Björn et al.: “Irrigation Treatment in Split-Thickness Skin Grafting of Intractable Leg Ulcers”, Scand J. Plast Reconstr. Surg., vol. 19, 1985, pp. 211-213. |
Svedman, P.: “A Dressing Allowing Continuous Treatment of a Biosurface”, IRCS Medical Science: Biomedical Technology, Clinical Medicine, Surgery and Transplantation, vol. 7, 1979, p. 221. |
Svedman, P. et al.: “A Dressing System Providing Fluid Supply and Suction Drainage Used for Continuous or Intermittent Irrigation”, Annals of Plastic Surgery, vol. 17, No. 2, Aug. 1986, pp. 125-133. |
K.F. Jeter, T.E. Tintle, and M. Chariker, “Managing Draining Wounds and Fistulae: New and Established Methods,” Chronic Wound Care, edited by D. Krasner (Health Management Publications, Inc., King of Prussia, PA 1990), pp. 240-246. |
G. {hacek over (Z)}ivadinovic, V. ukić, {hacek over (Z)}. Maksimović, Radak, and P. Pe{hacek over (s)}ka, “Vacuum Therapy in the Treatment of Peripheral Blood Vessels,” Timok Medical Journal 11 (1986), pp. 161-164 (certified translation). |
F.E. Johnson, “An Improved Technique for Skin Graft Placement Using a Suction Drain,” Surgery, Gynecology, and Obstetrics 159 (1984), pp. 584-585. |
A.A. Safronov, Dissertation Abstract, Vacuum Therapy of Trophic Ulcers of the Lower Leg with Simultaneous Autoplasty of the Skin (Central Scientific Research Institute of Traumatology and Orthopedics, Moscow, U.S.S.R. 1967) (certified translation). |
M. Schein, R. Saadia, J.R. Jamieson, and G.A.G. Decker, “The ‘Sandwich Technique’ in the Management of the Open Abdomen,” British Journal of Surgery 73 (1986), pp. 369-370. |
D.E. Tribble, “An Improved Sump Drain-Irrigation Device of Simple Construction,” Archives of Surgery 105 (1972) pp. 511-513. |
C.E. Tennant, “The Use of Hypermia in the Postoperative Treatment of Lesions of the Extremities and Thorax,” Journal of the American Medical Association 64 (1915), pp. 1548-1549. |
Selections from W. Meyer and V. Schmieden, Bier's Hyperemic Treatment in Surgery, Medicine, and the Specialties: A Manual of its Practical Application, (W.B. Saunders Co., Philadelphia, PA 1909), pp. 17-25, 44-64, 90-96, 167-170, and 210-211. |
V.A. Solovev et al., Guidelines, The Method of Treatment of Immature External Fistulas in the Upper Gastrointestinal Tract, editor-in-chief Prov. V.I. Parahonyak (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1987) (“Solovev Guidelines”). |
V.A. Kuznetsov & N.A. Bagautdinov, “Vacuum and Vacuum-Sorption Treatment of Open Septic Wounds,” in II All-Union Conference on Wounds and Wound Infections: Presentation Abstracts, edited by B.M. Kostyuchenok et al. (Moscow, U.S.S.R. Oct. 28-29, 1986) pp. 91-92 (“Bagautdinov II”). |
V.A. Solovev, Dissertation Abstract, Treatment and Prevention of Suture Failures after Gastric Resection (S.M. Kirov Gorky State Medical Institute, Gorky, U.S.S.R. 1988) (“Solovev Abstract”). |
V.A.C.® Therapy Clinical Guidelines: A Reference Source for Clinicians (Jul. 2007). |
International Search Report and Written Opinion for corresponding PCT/US2013/036805 mailed Jul. 4, 2013. |
Number | Date | Country | |
---|---|---|---|
20130280105 A1 | Oct 2013 | US |
Number | Date | Country | |
---|---|---|---|
61635655 | Apr 2012 | US |